These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 7686838
1. Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas. Gris JC, Schved JF, Marty-Double C, Mauboussin JM, Balmes P. Chest; 1993 Jul; 104(1):8-13. PubMed ID: 7686838 [Abstract] [Full Text] [Related]
2. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Nagayama M, Sato A, Hayakawa H, Urano T, Takada Y, Takada A. Cancer; 1994 Mar 01; 73(5):1398-405. PubMed ID: 8111706 [Abstract] [Full Text] [Related]
7. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts. Xiao Y, Bunn CL, Bartold PM. J Periodontal Res; 1998 Jan 01; 33(1):17-26. PubMed ID: 9524317 [Abstract] [Full Text] [Related]
10. Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry. Pappot H, Skov BG, Pyke C, Grøndahl-Hansen J. Lung Cancer; 1997 Jul 01; 17(2-3):197-209. PubMed ID: 9237155 [Abstract] [Full Text] [Related]
11. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas. Fujii T, Obara T, Tanno S, Ura H, Kohgo Y. Hepatogastroenterology; 1999 Jul 01; 46(28):2299-308. PubMed ID: 10521987 [Abstract] [Full Text] [Related]
12. The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study. Thewes M, Elsner E, Wessner D, Engst R, Ring J. Int J Dermatol; 2000 Mar 01; 39(3):188-91. PubMed ID: 10759957 [Abstract] [Full Text] [Related]
13. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Pedersen H, Brünner N, Francis D, Osterlind K, Rønne E, Hansen HH, Danø K, Grøndahl-Hansen J. Cancer Res; 1994 Sep 01; 54(17):4671-5. PubMed ID: 8062262 [Abstract] [Full Text] [Related]